Review of booster shots for Moderna, J&J vaccines just weeks away: Fauci
Sep 20, 2021
Fauci says that data on booster shots for those vaccines are only a few weeks away from a review by the FDA.
Study confirms virulence of SARS-CoV-2 variants of concern
Oct 05, 2021
The risks for hospitalization, ICU admission, death were up for N501Y-positive variants but were even more pronounced with the delta variant.
Medicare, many third-party insurers to cover coronavirus testing
By
Amy Novotney
Mar 10, 2020
Medicare and several leading insurers have committed to helping mitigate the costs associated with testing for and treating the novel coronavirus that has been spreading nationwide. In addition, officials...
Seniors had high burden of RSV-positive respiratory infection before COVID-19
Jan 23, 2023
Following a sharp decline during COVID-19, RSV-positive acute respiratory infection re-emerged during the summer of 2021 and is linked to lower quality of life.
New data show the power of COVID-19 vaccines
Aug 02, 2021
Data support what health experts have been saying for months: COVID-19 vaccines are highly effective at preventing serious illness and death.
Adults with IBD show antibody response to mRNA COVID-19 vaccine
Nov 09, 2021
After mRNA COVID-19 vaccination, 99% of patients with inflammatory bowel disease had detectable antibodies regardless of immunocompromising therapies.
Multisystem abnormalities persist after COVID-19 hospitalization
May 31, 2022
Persisting evidence of cardio-renal involvement and hemostasis pathway activation was reported at 28 to 60 days after discharge.
U.S. nursing home deaths reach lowest levels since pandemic began
Apr 05, 2022
Nursing home residents continue to be more vulnerable both because of their age and underlying medical conditions.
Baricitinib reduces mortality in critically ill adults with COVID-19
Feb 18, 2022
A reduction in death was seen at 28 and 60 days for patients receiving invasive mechanical ventilation and extracorporeal membrane oxygenation.
Racial, ethnic disparities seen in mAb treatment for COVID-19
Jan 19, 2022
Monoclonal antibody treatment was used infrequently among all racial, ethnic groups; Hispanics received mAbs less often than non-Hispanics.